This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]VC005 orally in Chinese healthy male volunteers.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
6
Take a suspension of 50 mg VC005 ,containing about 120 μCi \[14C\]VC005, in fasting within 5 minutes
The First Affiliated Hospital of Suzhou University
Suzhou, Jiangsu, China
Cumulative excretion rate of radioactivity in urine
Time frame: from 0 hour to 216 hours after administration
Cumulative excretion rate of radioactivity in feces
Time frame: from 0 hour to 216 hours after administration
Total radioactivity
Time frame: from 0 hour to 216 hours after administration
Adverse events
Time frame: From signing the ICF until 10 days after the dosing
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.